Viracta Therapeutics, Inc. (VIRX)

USD 0.21

(-4.22%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - 120 Thousand 2.07 Million 237 Thousand
Cost of Revenue 492 Thousand 210 Thousand 178 Thousand 32 Thousand - -902.74 Thousand
Gross Profit -492 Thousand -210 Thousand -178 Thousand 88 Thousand 2.07 Million 1.13 Million
Operating Expenses 50.69 Million 50.58 Million 25.79 Million 18.81 Million 25.36 Million 25.93 Million
Selling, General and Administrative Expenses 17.32 Million 24.32 Million 15.43 Million 5.34 Million 9.94 Million 11.32 Million
Research and Development Expenses 33.36 Million 26.26 Million 23.86 Million 13.46 Million 15.41 Million 14.61 Million
Other Expenses - 1.39 Million -13.5 Million -34 Thousand - -
Cost and Expenses 50.69 Million 50.58 Million 25.79 Million 18.81 Million 25.36 Million 25.94 Million
Operating Income -50.69 Million -50.58 Million 62.5 Million -18.81 Million -23.28 Million -25.71 Million
Interest Expense 3.7 Million 577 Thousand 491 Thousand 216 Thousand 514 Thousand 1.15 Million
Income Tax Expense - 577 Thousand 88.3 Million 182 Thousand 514 Thousand 1.15 Million
Earnings before Tax -51.05 Million -49.19 Million -114.76 Million -19.01 Million -23.33 Million -26.61 Million
Net Income -51.05 Million -49.77 Million -203.06 Million -19.19 Million -23.33 Million -26.61 Million
Earnings Per Share Basic -1.32 -1.32 -6.37 -206.93 -9.37 -26.18
Earnings Per Share Diluted -1.32 -1.32 -6.37 -206.93 -9.37 -26.18
Weighted Average Shares Outstanding 38.62 Million 37.79 Million 31.87 Million 92.77 Thousand 2.48 Million 1.01 Million
Weighted Average Shares Outstanding (Diluted) 38.62 Million 37.79 Million 31.87 Million 92.77 Thousand 2.48 Million 1.01 Million
Gross Margin - - - 0.73 1.00 4.81
EBIT Margin - - - -156.41 -5.82 -108.44
Profit Margin - - - -159.99 -11.25 -112.30
EBITDA -46.86 Million -48.41 Million -114.09 Million -18.76 Million -22.81 Million -25.45 Million
Earnings Before Tax Margin - - - -156.79 -11.23 -108.48

Income Statement Charts